Weblog met nieuws over de pharmaceutische industrie
10 Jun
Audience: Consumer ISSUE: FDA lab analyses found Via Xtreme Ultimate Sexual Enhancer Dietary Supplement for Men to contain sulfoaildenafil methanesulfonate, sulfosildenafil and dimethylsildenafil analogs of sildenafil. The active drug ingredients…
Audience: Consumer ISSUE: FDA lab analyses found Via Xtreme Ultimate Sexual Enhancer Dietary Supplement for Men to contain sulfoaildenafil methanesulfonate, sulfosildenafil and dimethylsildenafil analogs of sildenafil. The active drug ingredients…
10 Jun
Audience: Consumer [UPDATED 05/26/2011] All lots of Slim Xtreme Herbal Slimming Capsule, 30 Capsules/Bottle, are being recalled. The products were sold and distributed nationwide via the internet and at the company’s headquarters in Hollywood,…
Audience: Consumer [UPDATED 05/26/2011] All lots of Slim Xtreme Herbal Slimming Capsule, 30 Capsules/Bottle, are being recalled. The products were sold and distributed nationwide via the internet and at the company’s headquarters in Hollywood,…
10 Jun
Audience: OBGYN, Family Practice, Patient ISSUE: FDA is aware of two newly published studies that evaluated the risk of venous thromboembolism (VTE) in women who use birth control pills that contain drospirenone. The two recently published studies…
Audience: OBGYN, Family Practice, Patient ISSUE: FDA is aware of two newly published studies that evaluated the risk of venous thromboembolism (VTE) in women who use birth control pills that contain drospirenone. The two recently published studies…
18 Mar
Audience: Pharmacy
Bacteriostatic Sodium Chloride Injection, USP, 0.9%, 30 mL Multiple Dose Vials
Concentrated Sodium Chloride Injection, USP 23.4%, 30 mL Single Dose Vials and 100mL Pharmacy Bulk Packages
Sodium Thiosulfate Injection USP…
Audience: Pharmacy
Bacteriostatic Sodium Chloride Injection, USP, 0.9%, 30 mL Multiple Dose Vials
Concentrated Sodium Chloride Injection, USP 23.4%, 30 mL Single Dose Vials and 100mL Pharmacy Bulk Packages
Sodium Thiosulfate Injection USP…
17 Mar
[Posted 03/16/2011]
AUDIENCE: Consumer
ISSUE: FDA laboratory analysis confirmed that Black Ant contains sildenafil, the active ingredient in Viagra, an FDA approved prescription drug for Erectile Dysfunction (ED). The product tested had three…
[Posted 03/16/2011]
AUDIENCE: Consumer
ISSUE: FDA laboratory analysis confirmed that Black Ant contains sildenafil, the active ingredient in Viagra, an FDA approved prescription drug for Erectile Dysfunction (ED). The product tested had three…
10 Mar
Audience: Pharmacy, Consumer, Risk Manager [UPDATED 03/09/2011] Smith & Nephew issued a recall of IV PREP Antiseptic Wipes, manufactured for Smith & Nephew by The Triad Group.
[UPDATED 02/11/2011] Triad Alcohol Prep Pads are packaged with devices…
Audience: Pharmacy, Consumer, Risk Manager [UPDATED 03/09/2011] Smith & Nephew issued a recall of IV PREP Antiseptic Wipes, manufactured for Smith & Nephew by The Triad Group.
[UPDATED 02/11/2011] Triad Alcohol Prep Pads are packaged with devices…
9 Mar
Audience: Infectious Disease ISSUE: FDA notified healthcare professionals of serious health problems that have been reported in premature babies receiving Kaletra (lopinavir/ritonavir) oral solution. Kaletra oral solution contains the ingredients…
Audience: Infectious Disease ISSUE: FDA notified healthcare professionals of serious health problems that have been reported in premature babies receiving Kaletra (lopinavir/ritonavir) oral solution. Kaletra oral solution contains the ingredients…
7 Mar
Audience: Neurology, OB/GYN Available as generic topiramate
[Posted 03/04/2011]
ISSUE: FDA notified healthcare professionals and patients of an increased risk of development of cleft lip and/or cleft palate (oral clefts) in…
Audience: Neurology, OB/GYN Available as generic topiramate
[Posted 03/04/2011]
ISSUE: FDA notified healthcare professionals and patients of an increased risk of development of cleft lip and/or cleft palate (oral clefts) in…
3 Mar
Audience: Infectious Disease including Ziagen, Trizivir, and Epzicom
ISSUE: FDA updated the public about an ongoing safety review of abacavir and a possible increased risk of heart attack. There has been conflicting information on the potential…
Audience: Infectious Disease including Ziagen, Trizivir, and Epzicom
ISSUE: FDA updated the public about an ongoing safety review of abacavir and a possible increased risk of heart attack. There has been conflicting information on the potential…
3 Mar
Audience: Consumer, Family Practice, Pharmacy [Posted 03/02/2011]
ISSUE: FDA announced that it intends to remove certain unapproved prescription cough, cold, and allergy drug products from the U.S. market. Unapproved prescription cough, cold, and…
Audience: Consumer, Family Practice, Pharmacy [Posted 03/02/2011]
ISSUE: FDA announced that it intends to remove certain unapproved prescription cough, cold, and allergy drug products from the U.S. market. Unapproved prescription cough, cold, and…